Kyowa Kirin
Jean-David Rafizadeh-Kabe currently serves as the Global Operational Transformation Head at Kyowa Kirin, Inc., leading a team focused on global enterprise architecture transformation to enhance the company's mission in the pharmaceutical sector. Prior roles include Global Head of Pharmacovigilance at Kyowa Kirin Co. Ltd. and Vice President of Pharmacovigilance at Otsuka Pharmaceutical Company, Ltd. With extensive experience in pharmacovigilance, safety operations, and regulatory strategy across various companies including Bristol-Myers Squibb and Shin Nippon Biomedical Laboratories, Jean-David has held leadership positions in medical affairs and has a background in managing large medical organizations. Educational qualifications include an MD in Medicine from Université Claude Bernard Lyon 1 and degrees in International Relations, International Law, and Emergency Medicine from various esteemed institutions.
This person is not in any offices
Kyowa Kirin
5 followers
Kyowa Hakko Kirin Co., Ltd. is mainly engaged in medical product and Biochemical businesses. The Medical Product segment is engaged in the manufacture, sale and sales promotion of ethical drug and reagent for clinical test, the development of candidate substances for new drugs, as well as the research and development of technologies for antibody drug creation, among others. It also involved in the contracting, retail and wholesale, and insurance agency businesses. The Biochemical segment manufactures and sells medical and industrial materials, mainly amino and nucleic acids, and healthcare products. This segment also designs and constructs facilities.